IMPROVING LIVES WITH PRECISION DIAGNOSTICS
Live / Registered — Registered (as of 12 Jul 2022)
What this means for you
Registered since 12 Jul 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88153684
- Registration number
- 6789818
- Mark type
- Stylized text
- Filed
- 12 Oct 2018
- Published for opposition
- 26 Mar 2019
- Registered
- 12 Jul 2022
- Attorney of record
- Sarah W. Matthews
Goods and services
- Class 001 — Chemicals: Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
- Class 005 — Pharmaceuticals: Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in polymerase chain reaction, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
- Class 042 — Scientific and technological services: DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays; providing medical testing and consultation services for both clinical research and research applications
- Class 044 — Medical, beauty and agricultural services: DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays; providing information services regarding the diagnosis, monitoring and options in the treatment of leukemia; providing medical testing and consultation services for clinical applications
Owner
- Invivoscribe, Inc., San Diego, CA, US
- Invivoscribe, Inc., San Diego, CA, US
- Invivoscribe, Inc., San Diego, CA, US
Prosecution history
- 10 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Oct 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Oct 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Jul 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Jul 2022 — REGISTERED-PRINCIPAL REGISTER
- 07 Jun 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Jun 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 May 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 13 May 2022 — USE AMENDMENT FILED
- 13 May 2022 — TEAS STATEMENT OF USE RECEIVED
- 23 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Nov 2021 — SOU EXTENSION 5 GRANTED
- 15 Nov 2021 — SOU EXTENSION 5 FILED
- 20 Nov 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Nov 2021 — SOU TEAS EXTENSION RECEIVED